Aquestive Therapeutics to Present at the 2018 Wedbush Healthcare Conference

Tuesday, July 31, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

WARREN, N.J., July 31, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company

focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced that Keith Kendall, Chief Executive Officer, and John Maxwell,
Chief Financial Officer, will present at the 2018 Wedbush Healthcare Conference to be held in New York, NY on August 14-15.

Aquestive will present on Tuesday, August 14 at 12:45 p.m. Eastern Daylight Time (EDT). A webcast of the presentation will be available on the "Investors" section of the IR website. For more information, please visit investors.aquestive.com.

About Aquestive TherapeuticsAquestive Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies. As the leader in developing and delivering drugs via its PharmFilm® technology, Aquestive Therapeutics also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

Media inquiries:Christopher Hippolytechristopher.hippolyte@syneoshealth.com212-364-0458

Investor inquiries:Stephanie Carringtonstephanie.carrington@icrinc.com646-277-1282

Cision View original content:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-the-2018-wedbush-healthcare-conference-300688864.html

SOURCE Aquestive Therapeutics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store